ConductScience.org, home

Paper3865636

Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.

Silove ED and 2 others. Arch Dis Child, 1985. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease. Papers, record 3865636. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3865636

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.
PubMed
Journal
Arch Dis Child
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Silove EDE D
2Roberts DGD G
3de Giovanni JVJ V

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart Defects, CongenitalMajor topic
Prostaglandins EMajor topic
Administration, Oral
Dinoprostone
Drug Administration Schedule
Ductus Arteriosus, Patent
Female
Growth
Humans
Infant, Newborn
Infusions, Parenteral
Male
Pulmonary Artery
Radiography

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
156243E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation1976https://conductscience.org/library/papers/56243PubMed
26542338Prostaglandin E1 in suspected ductus dependent cardiac malformation.Arch Dis Child1984https://conductscience.org/library/papers/6542338PubMed
387761Oral prostaglandin E2 in pulmonary atresia.Lancet1979https://conductscience.org/library/papers/87761PubMed
47377820Necrotising enterocolitis after cardiac catheterisation in infants.Arch Dis Child1980https://conductscience.org/library/papers/7377820PubMed
57000997Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.J Pediatr1980https://conductscience.org/library/papers/7000997PubMed
67460252Oral prostaglandin E2 in ductus-dependent pulmonary circulation.Circulation1981https://conductscience.org/library/papers/7460252PubMed
77470344Pulmonary arterial structure in pulmonary atresia after prostaglandin E2 administration.Br Heart J1981https://conductscience.org/library/papers/7470344PubMed
87232045Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus.Pediatrics1981https://conductscience.org/library/papers/7232045PubMed
97285304Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.Circulation1981https://conductscience.org/library/papers/7285304PubMed
107285305Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.Circulation1981https://conductscience.org/library/papers/7285305PubMed
117062187Management of tricuspid atresia with orally administered prostaglandin E2.J Pediatr1982https://conductscience.org/library/papers/7062187PubMed
127092286Outcome of treatment for neonates referred to a supraregional cardiac centre 1976-78.Arch Dis Child1982https://conductscience.org/library/papers/7092286PubMed
137092307Necrotising enterocolitis after neonatal cardiac catheterisation.Arch Dis Child1982https://conductscience.org/library/papers/7092307PubMed
146956847Administration of E-type prostaglandins in ductus-dependent congenital heart disease.Pediatr Cardiol1982https://conductscience.org/library/papers/6956847PubMed
156681824Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.J Am Coll Cardiol1983https://conductscience.org/library/papers/6681824PubMed
166830290Congenital heart disease in the neonate: results of surgical treatment.Arch Dis Child1983https://conductscience.org/library/papers/6830290PubMed
176573159Pulmonary artery growth during treatment with oral prostaglandin E2 in ductus dependent cyanotic congenital heart disease.Arch Dis Child1983https://conductscience.org/library/papers/6573159PubMed
186537955Long-term prostaglandin E1 therapy in congenital heart defects.J Am Coll Cardiol1984https://conductscience.org/library/papers/6537955PubMed
19637973Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.Br Heart J1978https://conductscience.org/library/papers/637973PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
40927099Point-of-Care Ultrasound Optimizes the Preoperative Use of Prostaglandin E1 in Infants With Transposition of the Great Arteries.Rev Cardiovasc Med2025https://conductscience.org/library/papers/40927099PubMed
39044096Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review.Paediatr Drugs2024https://conductscience.org/library/papers/39044096PubMed
38332962Effectiveness of Alprostadil for Ductal Patency.J Pediatr Pharmacol Ther2024https://conductscience.org/library/papers/38332962PubMed
29486048Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29486048PubMed
22500225Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders.J Aging Res2012https://conductscience.org/library/papers/22500225PubMed
8582419Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.Eur J Pediatr1995https://conductscience.org/library/papers/8582419PubMed
8117134Assessment and management of congenital heart disease in the newborn by the district paediatrician.Arch Dis Child Fetal Neonatal Ed1994https://conductscience.org/library/papers/8117134PubMed
3767410Pharmacological manipulation of the ductus arteriosus.Arch Dis Child1986https://conductscience.org/library/papers/3767410PubMed
3281113Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.Pediatr Radiol1988https://conductscience.org/library/papers/3281113PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3865636

GET https://conductscience.org/api/papers/v1/3865636/authors